Use-dependent Electrophysiologic Effects of DL-sotalol and Modulation by Isoproterenol in the Human Ventricle.

スポンサーリンク

概要

• 論文の詳細を見る

• The interaction between dl-sotalol and isoproterenol on the ventricular effective refractory period (VERP) and conduction were examined in an electrophysiologic study of 9 patients at drug-free baseline, after 14 days of dlsotalol administration (320mg/day), and after the administration of isoproterenol. In all 9 patients, ventricular tachyarrhythmia could not be induced after dl-sotalol treatment. Isoproterenol was administered as a loading dosage of 0.025μg/kg for 5min with a maintenance dosage of 0.0025μg/kg/min. The VERP and the QRS duration were determined at paced cycle lengths of 600, 400 and 300msec. DL-sotalol and dl-sotalol+isoproterenol had no effect on ventricular conduction at the three cycle lengths. The VERP was significantly prolonged after dl-sotalol treatment at paced cycle lengths of 600 (241±16 to 302±28msec, p<0.001), 400 (223±21 to 280±23msec, p<0.001) and 300msec (202±16 to 256±24msec, p<0.005), but there was a parallel shift of the VERP, suggesting the absence of use-dependent effects on the VERP. The dl-sotalol-induced VERP prolongation was partially reversed by isoproterenol, but it remained significantly prolonged above baseline values at paced cycle lengths of 600 (241±16 to 281±18msec, p<0.01), 400 (223±21 to 258±20msec, p<0.01) and 300msec (202±16 to 247±22msec, p<0.01). The shortening of the VERP was greater at longer basic cycle lengths (600 and 400msec) than at the shorter paced cycle length (300msec, p<.05), but the percentage increase of the VERP was similar at the three basic cycle lengths of 600 (16%), 400 (15%) and 300 (20%)msec, indicating the lack of reverse use-dependency. The absence of reverse use-dependency of dl-sotalol on the VERP, even after isoproterenol administration, may be beneficial in the therapy of ventricular tachyarrhythmias and may account in part for the high efficacy of this drug.

著者

• Furushima Hiroshi

  First Department Of Internal Medicine Niigata University School Of Medicine

• Naitoh Naoki

  First Department Of Internal Medicine Niigata University School Of Medicine

• Taneda Koji

  First Department Of Internal Medicine Niigata Universaity School Of Medicine

• Aizawa Yoshifusa

  First Department Of Internal Medicine Niigata Universaity School Of Medicine

• Ohira Koji

  First Department Of Internal Medicine Niigata Universaity School Of Medicine

• OHIRA Koji

  First Department of Internal Medicine, Niigata University School of Medicine

• AIZAWA Yoshifusa

  First Department of Internal Medecine, Niigata University School of Medicine, Niigata, Japan.

関連論文

• Improved cardiac function after sirolimus-eluting stent placement in diabetic patients by pioglitazone : Combination therapy with statin
• PJ-474 The Effects of Erythropoietin-derivatives on Monocrotaline-induced Pulmonary Hypertension in Rats(PJ080,Pulmonary Circulation 1 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement
• PJ-366 Phase I/II Clinical Study of Angiogenic Therapy by Ex-Vivo Expanded Erythroblast Transplantation (EVEETA) for the Patients with Critical Limb Ischemia(PJ062,Regeneration (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Mee
• PJ-004 Clinical and ECG Characteristics as a Predictor of Recurrence of Ventricular Tachyarrhythmia (VTA) in Patients with Hypertrophic Cardiomyopathy (HCM)(PJ001,Arrhythmia, Others (Clinical/Pathophysiology) 1 (A),Poster Session (Japanese),The 73rd Annua
• Health-Related Quality of Life of Outpatients With Systolic and Isolated Diastolic Dysfunction : Sado Heart Failure Study
• 14-3-3 Protein Protects Against Cardiac Endoplasmic Reticulum Stress (ERS) and ERS-Initiated Apoptosis in Experimental Diabetes
• Lipocalin-2/Neutrophil Gelatinase-B Associated Lipocalin Is Strongly Induced in Hearts of Rats With Autoimmune Myocarditis and in Human Myocarditis
• Comparison of Antiarrhythmics Used in Patients With Paroxysmal Atrial Fibrillation : Subanalysis of J-RHYTHM Study
• Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation : J-RHYTHM Study(Arrhythmia/Electrophysiology)
• Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropiridine Calcium Antagonist for the Treatment of Paroxysmal Atrial Fibrillation in Patients With Hypertension : The J-RHYTHM II Study Design for the Investigation of Upstream Therapy for
• Japanese Randomized Trial for Investigation of a Combined Therapy of Amiodarone and Implantable Cardioverter Defibrillator in Patients With Ventricular Tachycardia and Fibrillation : The Nippon ICD Plus Pharmacologic Option Necessity (NIPPON) Study Design
• Potential Candidates for Cardiac Resynchronization Therapy in Japanese Patients With Idiopathic Dilated Cardiomyopathy : A Niigata Multicenter Study of DCM
• Significance of Early Onset and Progressive Increase of Activation Delay During Premature Stimulation in Brugada Syndrome
• Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation
• Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy
• Fenofibrate, a Peroxisome Proliferator-Activated Receptor α Activator, Suppresses Experimental Autoimmune Myocarditis by Stimulating the Interleukin-10 Pathway in Rats
• OE-389 Clinical Phenotype of Japanese LQT1 Form of Congenital Long QT Syndrome by Location and Coding Type From Japanese Multicenter Registry(Arrhythmia, diagnosis/Pathophysiology/EPS(02)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of
• PJ-692 Role of Faster Pacing and Magnesium (Mg) for the Treatment of Torsade de pointes (Tdp) Associated with Intravenous Amiodarone Administration(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scien
• PJ-688 The Abnormality of QT/RR Relationship in Brugada Syndrome and Idiopathic Ventricular Fibrillation without Prominent J-wave(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of T
• PJ-555 Distribution of Defibrillation Threshold (DFT) in Patients Treated with Implantable Cardioverter-Defibrillators (ICD) : Incidence and Characteristics of High DFT Patients(PJ093,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 2 (A),Poster Sess
• PJ-089 Characteristics of the Subsequent Recurrence of Ventricular Tachyarrhythmia in Patients under ICD Therapy, Concern of Driving(PJ015,ICD (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-105 Exercise-induced QT Interval Prolongation and Its Relation to the Cardiac Events in Long QT Syndrome (LQTS) Carrying KCNQ1-Mutations(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting
• 4 Role of Antiarrhythmic Drugs in Preventing Sudden Cardiac Death(Fighting Cardiac Sudden Death: Efficacy and Future,Roundtable Discussion 8 (RT-8) (A),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• 4 Relationship between Drug-Induced QT Prolongation and Bradycardia Dependent QT Prolongation : Usefulness for Risk Factors of Drug-induced Long QT Syndrome(Proarrhythmic Risk of Drugs and Their Evaluation,Symposium 7 (SY-07) (I),The 73rd Annual Scientifi
• Preservation of Renal Function in Response to Cardiac Resynchronization Therapy
• PJ-789 Measurement of defibrillation threshold in the patients treated with implantable cardioverter-defibrillator (ICD)(Arrhythmia, therapy(22)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Saphenous Vein Graft Shrinkage as a Mechanism of Stenosis Soon After Bypass Surgery
• PJ-294 Shortening of QT Interval by Mexiletine and It's Clinical Use in LQTl and LQT2(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-097 Intracoronary Acetylcholine (Ach) Induces a Greater QT Interval Prolongation and Torsade de Points (TdP) in LQT2 Than LQT1(Autonomic nervous system-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias
• Relationship Between Clinical Characteristics and Conduction Delay in the RVOT in Brugada Syndrome : Investigation of Signal-Averaged ECG in Precordial Leads(ECG/Body Surface Potential Mapping/Holter 2 (A), The 69th Annual Scientific Meeting of the Japane
• Role of Combined Medication Therapy for ICD Patients : Prognosis and ICD Discharge(Sudden Cardiac Death (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-429 Antiarrhythmic effects of magnesium sulfate for ventricular tachyarrhythmia developed under the condition of QT interval prolongation(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
• Imatinib Mesilate Inhibits Neointimal Hyperplasia via Growth Inhibition of Vascular Smooth Muscle Cells in a Rat Model of Balloon Injury
• Dose-Response Effects of Bepridil in Patients With Persistent Atrial Fibrillation Monitored With Transtelephonic Electrocardiograms : A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (J-BAF Study)
• OE-225 Guidelines for Chronic Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) in Mid Niigata Prefecture Earthquake 2004(Thromboembolism/Antithrombotic therapy/Thrombolysis-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Atrial Fibrillation Revisited : With a Special Reference to Primary Prevention
• Acute Pulmonary Thromboembolism Induced by Prophylactic Heparin Use and a Heparin-Coated Catheter : A Case of Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
• Regulation of Endothelial Nitric Oxide Synthase and Endothelin-1 Expression by Fluvastatin in Human Vascular Endothelial Cells
• The Usefulness of Holter Monitoring in Selecting Pharmacologic Therapy for Patients With Sustained Monomorphic Ventricular Tachycardia : Studies in Patients in Whom No Effective Pharmacologic Therapy Could be Determined by Electrophysiologic Study
• NET Na/K FLUX RATIO IN THE ERYTHROCYTE OF JAPANESE : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Hypertension
• Effect of Bepridil in Atrial Fibrillation Inducibility Facilitated by Vagal Nerve Stimulation : Prevention of Vagal Nerve Activation-Induced Shortening of the Atrial Action Potential Duration
• Efficacy of Procainamide and Lidocaine in Terminating Sustained Monomorphic Ventricular Tachycardia : Retrospective Case Series
• Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation
• Serum Hepcidin-20 is Elevated during the Acute Phase of Myocardial Infarction
• PJ-525 MPO and MPO-ANCA in Coronary Artery Circulation(PJ088,ACS/AMI (Clinical/Pathophysiology) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-353 Comparative Effects of Torasemide and Furosemide in Rats with Chronic Heart Hailure after Autoimmune Myocarditis(PE059,Heart Failure (Treatment) 2 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-167 Role of Mineralcorticoid Receptor Antagonist on Atrial Structural Remodeling in Hypertensive Rats(PE028,Heart Failure, Basic (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• 2 Evaluation of the Prospective Observation of Erythropoietin-Administration for the Treatment of Acute Myocardial Infarction (EPO-AMI)(Late Breaking Clinical Trials II,The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-103 Clinical Phenotype of Japanese LQT3 Form of Congenital Long QT Syndrome by Location of Mutation from Japanese Multicenter Registry(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting o
• FRS-117 Clinical and Electrocardiographic Characteristics of Japanese Probands with Brugada Syndrome with an SCN5A Mutation from Japanese Multicenter Registry(FRS24,Novel Mechanisms of Ventricular Arrhythmia (A),Featured Research Session (English),The 73r
• PJ-208 Impact of Frameshift Mutation and Nonsense-mediated mRNA Decay on Clinical Phenotype in LQT2 Form of Congenital Long QT Syndrome(Arrhythmia,diagnosis/Pathophysiology/EPS(13)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japa
• The Anti-Atherosclerotic Effects of Lipid Lowering with Atorvastatin in Patients with Hypercholesterolemia
• PE-415 Different Response to Exercise Testing between LQT7 Form of Congenital Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia(Exercise test/Cardiac rehabilitation(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting
• OJ-146 Lipocalin-2 a New Biomarker of Inflammatory Heart Disease?(OJ25,Myocarditis, Basic/ Clinical (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• -P155- Evaluation of Ventricular Vulnerability during Atrial Defibrillation through Implanted Transvenous Catheters in The Sterile Pericarditis Model(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• RADIOFREQUENCY CURRENT CATHETER ABLATION FOR SUSTAINED VENTRICULAR TACHYCARDIA
• Requirements of Non-pharmacologic Interventions in the Treatmrnt of Recurrent Sustained Ventricular Tachycardia : 53th Annual Scientific Session of the Japanese Circulation Society
• CONDUCTION THROUGH THE REENTRANT CIRCUIT IN RECURRENT SUSTAINED VENTRICULAR TACHYCARDIA EVALUATED BY USE OF TRANSIENT ENTRAINMENT
• Involvement of Mast Cells in the Development of Fibrosis in Rats with Postmyocarditis Dilated Cardiomyopathy(Miscellaneous)
• Inactivation of 14-3-3 Protein Exacerbates Cardiac Hypertrophy and Fibrosis through Enhanced Expression of Protein Kinase C β2 in Experimental Diabetes(Biochemistry/Molecular Biology)
• Expression of the TCL1 Gene at 14q32 in B-Cell Malignancies but Not in Adult T-Cell Leukemia
• High-Sensitivity CRP Reflects Insulin Resistance in Smokers
• VENTRICULAR TACHYCARDIA WITH TWO POSSIBLE EXITS FROM ONE RE-ENTRANT CIRCUIT
• OE-329 Ventricular tachyarrhytmia developed during treatment with class III antiarrhythmic drugs : arrhythmogenesis of slow heart rate and sympathetic nerve activity(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
• The Efficacy of DL-Sotalol in Reentrant Ventricular Tachycardia with Special Reference to the Width of the Zone of Entrainment
• Suppression of Myocardial Inflammation Using Suramin, A Growth Factor Blocker
• Changes in the Occurrence of Mechanical Alternans After Long-Term β-Blocker Therapy in Patients With Chronic Heart Failure
• Abnormal fatty acid matabolism in patients with coronary vasospasm
• Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency
• Electrophysiologic Parameters to Predict Clinical Recurrence of Ventricular Tachycardia in Patients Under Electrophysiologic Study-Guided Effective Pharmacological Therapy
• P013 Effect of Digoxin on Induction of Ventricular Arrhythmias after Atrial Defibrillation Shocks through Implanted Transvenous Catheter Electrodes in The Sterile Pericarditis Model of Atrial Fibrillation.
• P008 Characteristics of Excitable Gap in the Atrial Flutter Reentrant Circuit in the Canine Sterile Pericarditis Model.
• Recovery From Complete Atrioventricular Block Caused by Idiopathic Giant Cell Myocarditis After Corticosteroid Therapy
• PJ-049 A Comparison of Dilated Cardiomyopathy with Hypertrophic Cardiomyopathy in Efficacy of Implantable Cardioverter-Defibrillator(Arrhythmia, therapy-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OE-213 Evaluation of Adipocytokines, Proinflammatory Cytokines, and Inflammatory Markers in Coronary Sinus and Hepatic Venous Blood(Coronary circulation, basic/clinical-1 (IHD) OE36,Oral Presentation (English),The 70th Anniversary Annual Scientific Meetin
• OE-221 Role of Cardiac Resynchronization Therapy on Renal Function(Kidney/Renal circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Inappropriate Discharges by Fourth Generation Implantable Cardioverter Defibrillators in Patients With Ventricular Arrhythmias
• Difference in Ventricular Fibrillation interval between Structural Heart Disease and Brugada Syndrome : Role of Sotalol Treatmentand Defibrillation Threshold
• Severe Electrical Storm in Patients with Implantable CardioverterDefibrillators (ICD) : Does It Predict Poor Prognosis?
• Long-Term Outcomes of EP-Guided Sotalol Treatment for Sustained Ventricular Tachyarrhythmias
• RADIOFREQUENCY CURRENT CATHETER ABLATION FOR VENTRICULAR TACHYCARDIA
• Clinical characteristics of patients with inappropriate implantable cardioverter defibrillator(ICD)therapies : indication for dual-chamber ICD for sinus tachycardia
• Intramural Arrhythmogenesis of ECG Phenomenon of Prolonged QT Interval, Short-Long Cardiac Cycle and T Wave Alternans in Long QT Syndrome
• Arrhythmogenesis of Sympathetic Activity Related Ventricular Tachyarrhythmias in Type 3 Long QT Syndrome (LQT3)
• Effects of Class I and III Antiarrhythmic Drugs on Ventricular Tachycardia-Interrupting Critical Paced Cycle Length With Rapid Pacing
• Correlation Between the Effective Refractory Period and Activation-Recovery Interval Calculated From the Intracardiac Unipolar Electrogram of Humans With and Without dl-Sotalol Treatment
• Magnesium Treatment for Drug-Induced QT Prolongation
• A Comparison of Electrophysiologic Properties between Responders and Non-responders to DL-sotalol among Patients with Ventricular Tachyarrhythmia. Importance of the Lack of a Reverse Use-dependent Effect on Ventricular Refractoriness to Responders. : Impo
• Use-dependent Electrophysiologic Effects of DL-sotalol and Modulation by Isoproterenol in the Human Ventricle.
• Role of Sotalol and Nifekalant Therapy in Patients with Life-Threatening Ventricular Tachyarrhythmia
• Nicorandil Suppresses a Hump on the Monophasic Action Potential and Torsade de Pointes in a Patient with Idiopathic Long QT Syndrome.
• Comparison of Electrophysiologic Effects of Intravenous E-4031 and MS-551, Novel Class III Antiarrhythmic Agents, in Patients with Ventricular Tachyarrhythmias.
• Procainamide-Induced Changes in Reentrant Ventricular Tachycardia with Special Reference to the Tachycardia-Interrupting Critical Paced Cycle Length during Transient Entrainment with Rapid Pacing.
• Pleomorphic Ventricular Tachycardia Arising from a New Site during Antiarrhythmic Drug Therapy.
• Electrophysiologic Effects of Intravenous MS-551, a Novel Class III Antiarrhythmic Agent, on Human Atrium and Ventricle.
• Intracoronary Acetylcholine-induced Prolongation of Monophasic Action Potential in Long QT Syndrome.
• Both Low and High Energy Cardioversion Induced Accelerated Ventricular Tachycardia in a Patient Treated with an Implantable Cardioverter Defibrillator.
• Comparative Electrophysiologic Findings between Responders and Nonresponders to Class III Antiarrhythmic Drugs among Patients with Ventricular Tachyarrhythmia.

もっと見る 閉じる

スポンサーリンク